Wird geladen...
Different effects of SGLT2 inhibitors according to the presence and types of heart failure in type 2 diabetic patients
BACKGROUND: The effects of sodium-glucose cotransporter 2 inhibitor (SGLT2i) on cardiac function are not fully understood. We investigated the changes in cardiac function in diabetic patients according to the presence and types of heart failure (HF). METHODS: We retrospectively identified 202 diabet...
Gespeichert in:
| Veröffentlicht in: | Cardiovasc Diabetol |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7254690/ https://ncbi.nlm.nih.gov/pubmed/32466760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-020-01042-3 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|